User profiles for R. Halmosi
Róbert Dr. Halmosifull professor, University of Pecs Medical School Verified email at pte.hu Cited by 3612 |
[HTML][HTML] The effect of resveratrol on the cardiovascular system from molecular mechanisms to clinical results
… can activate the elements of the endogenous antioxidant system (GSH, SOD, CAT) [90],
and it has also beneficial effects on numerous signaling pathways having important roles in I/R …
and it has also beneficial effects on numerous signaling pathways having important roles in I/R …
Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease
K Magyar, R Halmosi, A Palfi, G Feher… - Clinical …, 2012 - content.iospress.com
Several beneficial effects of resveratrol (RES), a natural antioxidant present in red wine
have already been described. The aim of our study was to investigate if RES had a clinically …
have already been described. The aim of our study was to investigate if RES had a clinically …
Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA …
Aims Classification of acute heart failure (AHF) patients into four clinical profiles defined by
evidence of congestion and perfusion is advocated by the 2016 European Society of …
evidence of congestion and perfusion is advocated by the 2016 European Society of …
Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection …
…, I Milinković, A Grupper, R Halmosi… - European journal of …, 2021 - Wiley Online Library
Guideline‐directed medical therapy (GDMT) has the potential to reduce the risks of mortality
and hospitalisation in patients with heart failure (HF) with reduced ejection fraction (HFrEF). …
and hospitalisation in patients with heart failure (HF) with reduced ejection fraction (HFrEF). …
Effect of poly (ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart …
Ischemia-reperfusion induces reactive oxygen species (ROS) formation, and ROS lead to
cardiac dysfunction, in part, via the activation of the nuclear poly(ADP-ribose) polymerase (…
cardiac dysfunction, in part, via the activation of the nuclear poly(ADP-ribose) polymerase (…
In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine
Oxygen-free radicals play an important role in several physiologic and pathophysiologic
processes. In pathologic circumstances, they can modify and damage biologic systems. …
processes. In pathologic circumstances, they can modify and damage biologic systems. …
[HTML][HTML] Cardioprotective effect of resveratrol in a postinfarction heart failure model
… Oxidative stress is thought to play an important role in different cardiac pathological
conditions such as I/R injury, fibrosis, cardiac hypertrophy, remodeling, and heart failure [2]. …
conditions such as I/R injury, fibrosis, cardiac hypertrophy, remodeling, and heart failure [2]. …
Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug …
…, N Nyolczas, A Csaba Nagy, R Halmosi… - European journal of …, 2019 - Wiley Online Library
Aims To assess the proportion of patients with heart failure and reduced ejection fraction (HFrEF)
who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines …
who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines …
PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats
…, E Szabados, T Kálai, K Hideg, R Halmosi… - Cardiovascular …, 2009 - academic.oup.com
Aims Oxidative stress followed by abnormal signalling can play a critical role in the development
of long-term, high blood pressure-induced cardiac remodelling in heart failure (HF). …
of long-term, high blood pressure-induced cardiac remodelling in heart failure (HF). …
Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound
Doxorubicin is a widely used anticancer agent, but its application is restricted by its cardiotoxic
side effects. The current theory of its cardiotoxicity is based on free radical formation. The …
side effects. The current theory of its cardiotoxicity is based on free radical formation. The …